Appili Therapeutics Inc. (TSX:APLI)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Aug 10, 2026, 9:08 AM EST
Appili Therapeutics Market Cap
Appili Therapeutics has a market cap or net worth of CAD 1.32 million as of August 11, 2026. Its market cap has decreased by -45.42% in one year.
Market Cap
1.32M
Enterprise Value
14.22M
Revenue
244.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since June 25, 2019, Appili Therapeutics's market cap has decreased from 26.83M to 1.32M, a decrease of -95.07%. That is a compound annual growth rate of -34.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 1.32M | -58.75% |
| Dec 29, 2025 | 3.21M | -24.39% |
| Dec 30, 2024 | 4.24M | - |
| Dec 29, 2023 | 4.24M | -22.22% |
| Dec 30, 2022 | 5.46M | -33.42% |
| Dec 31, 2021 | 8.20M | -89.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 4.10M |
| Grey Matters Health | 3.61M |
| Quest PharmaTech | 3.38M |
| Rakovina Therapeutics | 3.17M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 2.22M |
| MindBio Therapeutics | 1.82M |
| Universal Ibogaine | 1.56M |